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The previously suggested method of following ligand-receptor interactions by measuring ligand-induced changes in mem- 
brane fluidity [(1986) FEBS Lett. 194, 313-3161 was employed to study the binding of specific ligands of the muscarinic 
receptor to rat brain membrane fragments containing a fluorescent analogue of phosphatidylcholine (APC) as a mem- 
brane probe. Upon addition of carbachol and atropine in low concentrations the fluorescence polarization of the APC- 
labeled membranes decreased significantly demonstrating that binding of these ligands to the muscarinic receptor in- 
creases the fluidity of its lipid environment. The fluidity changes were specific, concentration-dependent and saturable. 
In comparison with radioligand assays the fluorescent lipid probe method proved to be much more sensitive but the Kd 
values obtained by the two methods differed considerably. 
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1. INTRODUCTION 
Recently a new approach to the study of ligand- 
receptor interaction based on measurement of 
membrane fluidity changes caused by specific 
receptor binding was proposed [l]. In the present 
study we made use of this approach to investigate 
the interaction of specific ligands with the 
muscarinic acetylcholine receptor in rat brain. It 
has been shown that addition of muscarinic 
agonists to intact lymphocytes results in fluidity 
changes of the cell membrane [2]. This 
phenomenon detected by making use of DPH as a 
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fluorescent probe can have two explanations. 
Firstly, the binding of ligands with the receptor 
protein can change direct receptor-membrane in- 
teractions. Secondly, the alteration of membrane 
properties can be brought about by changing some 
metabolic processes of the intact cell modulated by 
the muscarinic receptor [3]. 
In the present study the interrelationship be- 
tween binding of specific ligands with the 
muscarinic receptor and changes of fluidity of its 
lipid environment has been studied in a cell-free 
system: membrane fragments from rat cerebral 
cortex. Application of this model system facilitates 
the interpretation of fluorescence data as com- 
pared to living cells. The fluorescent probe 
APC (1-acyl-2-t 12-(9-anthryl)-1 l-trans-dodecen- 
oyl]-sn-glycero-3-phosphocholine), closely related 
to phosphatidylcholine, the main lipid component 
of the native membrane, has been used to follow 
the fluidity changes of the membrane fragments. 
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2. EXPERIMENTAL 
Suspensions of membrane fragments from rat cerebral cortex 
were prepared as described earlier [4]. The concentration of 
muscarinic receptor sites in the membranes was 0.2 nM as 
determined by a radioligand binding assay using L- 
[‘Hlquinuclidinyl benzilate [4]. The fluorescent probe APC was 
synthesized as described in [5]. 
Membrane fragments were incubated with APC in 0.05 M K- 
phosphate buffer for 3 h at 25°C. The molar ratio of APC to 
membrane phospholipids was 1:lOO. The final level of 
fluorescence intensity of the APC-labeled membrane prepara- 
tion exceeded that of the membrane blank more than 20-fold. 
All fluorescence measurements were performed on a com- 
puterized spectrofluorimeter SFR-100 (Baird, England). The 
values of fluorescence polarization were determined in the ex- 
citation spectrum at excitation and emission slits 2 nm and 
5 nm, respectively. The excitation and emission wavelengths 
were 370 nm and 440 nm, respectively. 
In order to measure the fluidizing effect of the muscarinic 
ligands added to the membrane suspension, the fluorescence 
polarization was determined before and after incubation of the 
APC-labeled membranes with different concentrations of car- 
bamoylcholine chloride (Sigma) and of atropine sulfate (Merck) 
for 10 min at 25°C. All experiments were carried out in 
triplicate and the mean values were used in the following 
analysis. 
3. RESULTS AND DISCUSSION 
The lipid fluorescent probe APC effectively in- 
corporated into membrane fragments from rat 
cerebral cortex. This process can be followed by 
the increase in fluorescence intensity due to the 
decay of self-quenching, as the probe molecules 
entering the lipid bilayer depart from each other. 
The excitation spectrum of APC incorporated into 
the membrane fragments is shown in fig.1. The 
considerable energy transfer from the tryp- 
tophanyl groups of membrane proteins lends addi- 
tional evidence for its localization in the membrane 
structure (not shown). 
Addition of muscarinic ligands to the suspension 
of APC-labeled membrane fragments led to a con- 
siderable decrease in the fluorescence polarization 
of the probe (fig.2). The effects observed clearly 
point to fluidization of the probes microenviron- 
ment in the cases of both carbachol and atropine. 
At the same time no changes in the fluorescence 
polarization occurred when atropine (10e9 M) was 
added to liposomes prepared by sonication of the 
total lipids of brain membranes with the APC 
probe. Thus the alteration of the physical 
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Fig. 1. Excitation spectrum of APC incorporated into rat brain 
membrane fragments. 
parameters of the membrane seems to arise from 
interaction between the ligands and the muscarinic 
receptor molecule whose conformational changes 
are transferred to the surrounding lipids. This sug- 
gestion is supported by the observation that the 
fluorescence polarization decreases rapidly within 
l-2 min after addition of the ligands and then re- 
mains constant for several hours. 
The sensitivity of the probes response to ligand 
binding was high. Statistically significant changes 
in the fluorescence polarization of APC could be 
registered already at lo-l2 M carbachol or 
atropine, which is about two orders less than the 
minimal concentration measurable in radioligand 
binding experiments. At the same time diphenyl- 
hexatriene and the sphingomyelin analogue of 
APC [6] introduced into the membrane prepara- 
tion did not respond to ligand addition at 25°C. 
These differences indicate that ligand-receptor 
binding initiates fluidity changes in some lipid do- 
mains of the membrane, while others are ap- 
parently not affected. 
Binding of carbachol with the muscarinic recep- 
tor gave a maximal decrease of the fluorescence 
polarization of APC at nanomolar ligand concen- 
trations and the magnitude of this effect reached 
up to 22% of the initial polarization value. Further 
increase in carbachol concentration up to 1 M did 
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Fig.2. Changes in fluorescence polarization of membrane- 
incorporated APC after addition of muscarinic ligands to rat 
brain membrane fragments: curve 1, carbachol; 2, atropine; 3, 
tetramethylammonium chloride. Incubation time, 10 min. 
AP = P - PO where P, and P are the fluorescence polarization 
values before and after addition of the ligand. 
not lead to additional changes in the fluorescence 
polarization (fig.2). 
Similar fluidization of the lipid environment of 
APC was detected after addition of the specific 
muscarinic antagonist atropine to brain membrane 
fragments. In this case, however, the maximal ef- 
fect was considerably smaller, comprising only 
11% of the initial fluorescence polarization value 
(fig.2). 
Thus the maximal change in polarization of the 
APC fluorescence brought by the action of an 
agonist carbachol or an antagonist atropine with 
the muscarinic receptor was different. We suppose 
that agonist binding with the receptor results in 
more significant conformational transition of the 
protein that causes larger rearrangements in the 
membrane lipid structure. 
The influence of muscarinic ligands on mem- 
brane fluidity is a specific effect because 
tetramethylammonium chloride, a very weak 
ligand of the muscarinic receptor had no effect on 
the fluorescence polarization of the probe at ligand 
concentrations up to 10d6 M and only a slight ef- 
feet was observed at 10e5 M (fig.2). Moreover as 
can be concluded from the data in fig.3 atropine 
and carbachol compete for the receptor. 
We found that keeping the APC-labeled mem- 
brane fragments for several days at 4°C led to a 
complete loss of sensitivity of the lipid phase to 
carbachol or atropine. Under the same conditions 
radioligand measurements did not reveal any con- 
siderable changes in binding of L-t3H]quinu- 
clidinyl benzilate with the membranes [4]. Thus the 
membrane fluidization brought about by the 
muscarinic receptor-ligand interaction appears to 
be a specific property of the native receptor- 
membrane complex. 
The fluidization effect caused by binding of car- 
bachol or atropine with the muscarinic receptor 
follows a simple binding isotherm (fig.3) that 
makes it possible to determine the apparent Kd 
values for these ligands. Treatment of these ex- 
perimental data according to the Hill equation 
yielded linear dependencies (fig.4). The Kd values 
obtained by this method were 3 pM for atropine 
and 5 pM for carbachol. However, the low value 
of the Hill coefficient nH = 0.54 for carbachol 
points to the presence of heterogeneous binding 
sites or to negative cooperativity of the binding 
process. 
It is important to emphasize that physiological 
experiments based on measurement of tissue 
responses to muscarinic stimulation, such as mus- 
cle contraction and inhibition of adenylate cyclase, 
have yielded Kd values from 63 nM to 0.12 mM for 
carbachol and from 0.26 nM to 14pM for 
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Fig.3. Fluorescence polarization values of membrane- 
incorporated APC after addition of 1O-8 M carbachol (1) and 
10m8 M atropine after carbachol (2). 
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occupation of only a small part of the receptor 
sites seems to be sufficient to induce maximal 
alteration of the lipid organization. 
Finally, the difference in ligand concentrations 
necessary to create physical or physiological effects 
supports the view that the physical state of 
biomembranes can be directly regulated by 
receptor-ligand interaction and that the physiologi- 
cal responses following receptor occupation can be 
either secondary effects or are not related to altera- 
tion of membrane fluidity. 
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